E-LIB Suche - Ergebnisse für: Marshall, John K

1

902 TOFACITINIB FOR HOSPITALIZED ACUTE SEVERE ULCERATIVE CO..:

Narula, Neeraj ; Peerani, Farhad ; Hansen, Tawnya...
Gastroenterology. 166 (2024) 5 - p. S-216 , 2024

Link: https://doi.org/10.1016/..

2

Tu1838 DELAYED USTEKINUMAB AND ADALIMUMAB RESPONDERS HAVE S..:

Narula, Neeraj ; Wong, Emily C. ; Dulai, Parambir S....
Gastroenterology. 166 (2024) 5 - p. S-1430 , 2024

Link: https://doi.org/10.1016/..

3

1159 ASSOCIATION OF ULTRA-PROCESSED FOODS WITH GUT MICROBIO..:

Vagianos, Kathy ; Neustaeter, Anna ; Waslyk, Alyssa M....
Gastroenterology. 166 (2024) 5 - p. S-273 , 2024

Link: https://doi.org/10.1016/..

4

The relationship among vedolizumab drug concentrations, bio..:

Seow, Cynthia H ; Marshall, John K ; Erin, Stewart...
Journal of the Canadian Association of Gastroenterology. , 2024

Link: https://doi.org/10.1093/..

5

Su1776 EFFICACY AND SAFETY OF ETRASIMOD AS A FIRST-LINE ADV..:

Sonnenberg, Elena ; Lees, Charlie W. ; Baert, Filip J....
Gastroenterology. 166 (2024) 5 - p. S-808 , 2024

Link: https://doi.org/10.1016/..

6

Environmental Factors Associated with Risk of Crohn's Disea..:

Xue, Mingyue ; Leibovitzh, Haim ; Jingcheng, Shao...
Clinical Gastroenterology and Hepatology. , 2024

Link: https://doi.org/10.1016/..

7

Adaptive Steroid Tapering Impedes Corticosteroid-free Remis..:

Narula, Neeraj ; Hamam, Hasan ; Liu, Jasmine...
Journal of Crohn's and Colitis. , 2024

Link: https://doi.org/10.1093/..

8

318 ACCEPTABILITY, FEASIBILITY, AND IMPACT OF THE MYGUT DIG..:

Zhen, Jamie ; Simoneau, Maude ; Germain, Pascale...
Gastroenterology. 166 (2024) 5 - p. S-70-S-71 , 2024

Link: https://doi.org/10.1016/..

9

Sa1796 OPTIMAL ENDOSCOPIC HEALING THRESHOLDS DEFINED BY MM-..:

Narula, Neeraj ; Wong, Emily C. ; Dulai, Parambir S....
Gastroenterology. 166 (2024) 5 - p. S-527 , 2024

Link: https://doi.org/10.1016/..

10

Mo1753 IDENTIFYING BLOOD BIOMARKERS THAT PREDICT INFLAMMATO..:

Wong, Emily C. ; Narula, Neeraj ; Perrot, Nicolas...
Gastroenterology. 166 (2024) 5 - p. S-1097-S-1098 , 2024

Link: https://doi.org/10.1016/..

11

Defining Endoscopic Remission in Crohn's Disease: MM-SES-CD..:

Narula, Neeraj ; Wong, Emily C.L. ; Dulai, Parambir S....
Clinical Gastroenterology and Hepatology. 22 (2024) 8 - p. 1687-1696.e6 , 2024

Link: https://doi.org/10.1016/..

12

Vedolizumab and Adalimumab in Biologic-Naïve Ulcerative Col..:

Narula, Neeraj ; Wong, Emily C. L. ; Dulai, Parambir S....
Digestive Diseases and Sciences. , 2023

Link: https://doi.org/10.1007/..

13

1236 FIRST-DEGREE RELATIVES OF PATIENTS WITH CROHN'S DISEAS..:

Olivera, Pablo A. ; Martinez-Lozano, Helena ; Leibovitzh, Haim...
Gastroenterology. 164 (2023) 6 - p. S-254 , 2023

Link: https://doi.org/10.1016/..

14

1233 BILE ACID COMPOSITION, DIETARY FAT, AND CROHN'S DISEAS..:

Neustaeter, Anna ; Shao, Jingcheng ; Xue, Mingyue...
Gastroenterology. 164 (2023) 6 - p. S-253 , 2023

Link: https://doi.org/10.1016/..

15

Gut Microbiome Composition Is Associated With Future Onset ..:

Raygoza Garay, Juan Antonio ; Turpin, Williams ; Lee, Sun-Ho...
Gastroenterology. 165 (2023) 3 - p. 670-681 , 2023

Link: https://doi.org/10.1053/..